Drawing for LORZELTI

USPTO serial 79313580

LORZELTI

Reviewed by CopyMark Law Group

Reg. 6897514Status 700Registered
Filing date
Status date
Registration date
Nov 15, 2022
Examiner
OH, HYUN-JUNG
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LORZELTI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 23, 2023GPNXNOTIFICATION PROCESSED BY IB—
Dec 21, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 20, 2022FIMPFINAL DISPOSITION PROCESSED—
Dec 15, 2022GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Nov 15, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 15, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 30, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 30, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 10, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 27, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 27, 2022ATRVATTORNEY REVIEW COMPLETED—
Jun 15, 2022CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
May 3, 2022FINAFINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Mar 28, 2022ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Feb 23, 2022CRTPREG. CANCELLED - RESTORED TO PENDENCY—
Feb 22, 2022APETASSIGNED TO PETITION STAFF—
Feb 17, 2022RCIIREQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED—
Feb 10, 2022GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jan 31, 2022ES7RTEAS SECTION 7 REQUEST RECEIVED—
Jan 11, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 23, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Oct 26, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 26, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 17, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 16, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 15, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 9, 2021DOCKASSIGNED TO EXAMINER—
Jul 9, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 9, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 9, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 9, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 9, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 9, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 6, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 2, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 1, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 17, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance